JP6925328B2 - ヒストン修飾及びバリアントを含むヌクレオソームを検出するための方法 - Google Patents

ヒストン修飾及びバリアントを含むヌクレオソームを検出するための方法 Download PDF

Info

Publication number
JP6925328B2
JP6925328B2 JP2018520476A JP2018520476A JP6925328B2 JP 6925328 B2 JP6925328 B2 JP 6925328B2 JP 2018520476 A JP2018520476 A JP 2018520476A JP 2018520476 A JP2018520476 A JP 2018520476A JP 6925328 B2 JP6925328 B2 JP 6925328B2
Authority
JP
Japan
Prior art keywords
histone
nucleosome
sample
isoform
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018520476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018536849A5 (enExample
JP2018536849A (ja
Inventor
ビンセント ミカレフ ジャコブ
ビンセント ミカレフ ジャコブ
エドワード エックレストン マーク
エドワード エックレストン マーク
Original Assignee
ベルジアン ボリション エスピーアールエル
ベルジアン ボリション エスピーアールエル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベルジアン ボリション エスピーアールエル, ベルジアン ボリション エスピーアールエル filed Critical ベルジアン ボリション エスピーアールエル
Publication of JP2018536849A publication Critical patent/JP2018536849A/ja
Publication of JP2018536849A5 publication Critical patent/JP2018536849A5/ja
Application granted granted Critical
Publication of JP6925328B2 publication Critical patent/JP6925328B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2018520476A 2015-10-21 2016-10-21 ヒストン修飾及びバリアントを含むヌクレオソームを検出するための方法 Active JP6925328B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1518674.5A GB201518674D0 (en) 2015-10-21 2015-10-21 Method for detecting nuleosomes containing histone modifications and variants
GB1518674.5 2015-10-21
PCT/GB2016/053288 WO2017068359A1 (en) 2015-10-21 2016-10-21 Method for detecting nucleosomes containing histone modifications and variants

Publications (3)

Publication Number Publication Date
JP2018536849A JP2018536849A (ja) 2018-12-13
JP2018536849A5 JP2018536849A5 (enExample) 2019-12-05
JP6925328B2 true JP6925328B2 (ja) 2021-08-25

Family

ID=55131420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018520476A Active JP6925328B2 (ja) 2015-10-21 2016-10-21 ヒストン修飾及びバリアントを含むヌクレオソームを検出するための方法

Country Status (6)

Country Link
US (1) US10768182B2 (enExample)
EP (1) EP3365681B1 (enExample)
JP (1) JP6925328B2 (enExample)
CN (1) CN108496083A (enExample)
GB (1) GB201518674D0 (enExample)
WO (1) WO2017068359A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016128383A1 (en) 2015-02-10 2016-08-18 B.R.A.H.M.S Gmbh Free histone proteins as biomarkers
BR112022010774A2 (pt) * 2019-12-02 2022-08-23 Belgian Volition Srl Uso de nucleossomos livres de células como biomarcadores
GB202108185D0 (en) 2021-06-08 2021-07-21 Belgian Volition Sprl Standardisation of nucleosome assays using biologically derived calibrants
CN113480646B (zh) * 2021-07-01 2022-03-15 中国科学院生物物理研究所 特异性结合h1.4移码突变蛋白的单克隆抗体制备及其应用
GB202117799D0 (en) 2021-12-09 2022-01-26 Belgian Volition Srl Method for the detection of blood cancer
EP4490323A1 (en) 2022-03-11 2025-01-15 Belgian Volition SRL Differential diagnosis method
GB202205212D0 (en) 2022-04-08 2022-05-25 Belgian Volition Sprl Method for transplant organ health assessment
WO2024133225A1 (en) 2022-12-19 2024-06-27 Belgian Volition Srl Calibration
WO2024213795A1 (en) 2023-04-14 2024-10-17 Belgian Volition Srl Diagnosis method using cell free nucleosome levels
WO2024223947A1 (en) 2023-04-28 2024-10-31 Belgian Volition Srl Use of cell free nucleosomes as biomarkers of carcinomas
GB202307768D0 (en) 2023-05-24 2023-07-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
GB202310137D0 (en) 2023-07-03 2023-08-16 Belgian Volition Srl Method for the detection of cancer
WO2025061853A1 (en) 2023-09-19 2025-03-27 Belgian Volition Srl Lateral flow test device
WO2025094148A1 (en) * 2023-11-03 2025-05-08 Onchilles Pharma, Inc. Histone h1 levels as biomarkers for cancer therapy
CN117904196B (zh) * 2024-01-05 2024-07-12 安徽大学 一种非小细胞肺癌组蛋白h1.4赖氨酸乙酰化点突变细胞模型的构建及其应用
WO2025181348A1 (en) 2024-03-01 2025-09-04 Belgian Volition Srl Method for determining the origin of circulating dna

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
EP2577313A1 (en) * 2010-06-03 2013-04-10 Porto Conte Ricerche S.r.l. Biomarkers for lung neuroendocrine tumors
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
SG10201604081YA (en) * 2011-12-07 2016-07-28 Singapore Volition Pte Ltd Method for detecting nucleosome adducts
EP3757210B1 (en) * 2012-03-02 2022-08-24 Sequenom, Inc. Methods for enriching cancer nucleic acid from a biological sample
GB201303575D0 (en) 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes

Also Published As

Publication number Publication date
WO2017068359A1 (en) 2017-04-27
CN108496083A (zh) 2018-09-04
GB201518674D0 (en) 2015-12-02
EP3365681A1 (en) 2018-08-29
EP3365681B1 (en) 2023-06-07
US10768182B2 (en) 2020-09-08
US20190064183A1 (en) 2019-02-28
JP2018536849A (ja) 2018-12-13

Similar Documents

Publication Publication Date Title
JP6925328B2 (ja) ヒストン修飾及びバリアントを含むヌクレオソームを検出するための方法
US20230116530A1 (en) Method for detecting nucleosomes containing histone variants
US20200347435A1 (en) Method for detecting nucleosomes containing nucleotides
US9222937B2 (en) Method for detecting nucleosomes
JP2015500478A (ja) ヌクレオソームアダクト検出法
US20170003296A1 (en) Method for detecting histone modifications in nucleosomes
HK1253354B (en) Method for detecting nucleosomes containing histone variants
HK1199761B (en) Method for detecting nucleosomes
HK1199758B (en) Method for detecting nucleosomes containing histone variants
HK1199760B (en) Method for detecting nucleosomes containing nucleotides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191016

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191016

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200826

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20201130

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210609

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210609

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210621

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210622

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210713

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210803

R150 Certificate of patent or registration of utility model

Ref document number: 6925328

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250